Altria Group (MO)
Sells Marlboro cigarettes, oral tobacco, nicotine pouches and NJOY e-vapor products.
Something off on this page? Send us feedback.
Sells Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal moist smokeless tobacco, on! nicotine pouches, and NJOY e-vapor products, primarily in the United States. Pricing and brand scale support the cigarette franchise as volumes decline, while FDA oversight, state settlement payments, and NJOY patent restrictions shape the business.
Owns U.S. nicotine businesses spanning Marlboro cigarettes, Black & Mild machine-made cigars, Copenhagen and Skoal moist smokeless tobacco, on! oral nicotine pouches, and NJOY e-vapor products. Marlboro remains the country’s largest-selling cigarette brand and is sold principally through wholesalers and large retail chains.
Uses pricing to offset declining cigarette shipments while expanding on! and on! PLUS. NJOY ACE, its principal e-vapor product, is barred from U.S. importation and sale under an International Trade Commission patent order. Equity investments in AB InBev and Cronos sit outside the core operating portfolio.
Generates substantially all revenue from U.S. customers. FDA rules govern product authorization and marketing; state settlement payments and tobacco litigation remain continuing obligations.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 11, 2026 | Barclays | Reiterate | Rating: —Target: $64 | Target: $58 |
| Jul 21, 2026 | BTIG | Initiate | Rating: — | |
| Jul 7, 2026 | UBS | Reiterate | Rating: —Target: $76 | Target: $79 |
| May 15, 2026 | Barclays | Reiterate | Rating: —Target: $63 | Target: $64 |
| May 4, 2026 | Deutsche Bank | Target | Target: $60 | Target: $66 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $2.37B · Total debt $24.58B · Total assets $33.37B · Shareholders' equity −$2.67B
- Revenue
- $6.11B
- Operating income
- $3.14B
- Net income
- $2.30B
HistoryDividendAnnual yield
| Institutions | 67.63% | 1.13B shares | |
|---|---|---|---|
| 2,647 holders · as of Jun 30, 2026 | |||
| Insiders | 0.14% | 2.29M shares | |
| 19 holders · as of Sep 11, 2026 | |||
| Other | 32.23% | 538.13M shares | |
| remainder | |||
1.67B company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 7.55% | 126.07M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.53% | 109.03M | as of Jun 30, 2026 |
State Street CorpInstitution | 4.20% | 70.19M | as of Jun 30, 2026 |
Charles Schwab Investment Management IncInstitution | 3.54% | 59.12M | as of Jun 30, 2026 |
Sixth Street Partners Management Company, L.P.Institution | 3.54% | 59.12M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 9, 2026 | KATHRYN B. McQUADE | director | +1,500 | $67.62 |
| May 26, 2026 | Ellen R. Strahlman | director | −2,000 | $72.56 |
| May 26, 2026 | Ennis Debra J. Kelly | director | −5,790 | $72.25 |
| Mar 5, 2026 | Charles N. Whitaker | officer: SVP, Chief HR Off. & CCO | −27,908 | $67.57 |
- British American Tobacco (ADR)
Broadest US rival across cigarettes, e-vapor, oral pouches, and moist snuff.
- Philip Morris International
Smoke-free rival: Zyn dominates US oral pouches, IQOS re-enters US market.
- Turning Point Brands
Value smokeless rival; FRE/ALP pouches growing fast vs on! in the US market.
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Altria Group | $68.64 | −0.01% | $114.44B | 14.5 | 11.9 | 5.2 | +1.3% |
| British American Tobacco (ADR) | $55.75 | +0.03% | $120.25B | 14.3 | — | 3.5 | −0.1% |
| Philip Morris International | $190.24 | +0.01% | $292.21B | 26.9 | 21.7 | 6.9 | +10.4% |
| Turning Point Brands | $60.28 | −0.17% | $1.19B | 26.3 | 55.5 | 2.3 | +22.6% |
| Median | 26.3 | 38.6 | 3.5 | +10.4% |